Dr. Wendy Stock, MD
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Expert in Childhood Cancer
Studies Acute Lymphoblastic Leukemia
13 reported clinical trials
44 drugs studied
Area of expertise
1Childhood Cancer
Global LeaderBCR-ABL1 positive
CD22 positive
AST positive
2Acute Lymphoblastic Leukemia
BCR-ABL1 positive
CD22 positive
AST positive
Affiliated Hospitals
Clinical Trials Wendy Stock, MD is currently running
Venetoclax + Chemotherapy
for Leukemia
This research study is studying a medication called Venetoclax and a chemotherapy regimen as a possible treatment for Acute Lymphoblastic Leukemia. The drugs involved in this study are: * Venetoclax * Standard Chemotherapy (which includes cyclophosphamide, vincristine, doxorubicin, dexamethasone, methotrexate, 6-mercaptopurine, etoposide, and cytarabine
Recruiting3 awards Phase 1 & 2
Ruxolitinib + Chemotherapy
for Acute Lymphoblastic Leukemia
This study will test if adding ruxolitinib to standard multi-drug chemotherapy regimen will be safe and tolerated in adolescents and young adults with newly diagnosed Ph-like acute lymphoblastic leukemia (ALL).
Recruiting3 awards Phase 1
More about Wendy Stock, MD
Clinical Trial Related7 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Wendy Stock, MD has experience with
- Inotuzumab Ozogamicin
- Venetoclax
- Cytarabine
- Doxorubicin
- Text Messages
- Nivolumab
Breakdown of trials Wendy Stock, MD has run
Childhood Cancer
Acute Lymphoblastic Leukemia
Lymphoma
Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Wendy Stock, MD specialize in?
Wendy Stock, MD focuses on Childhood Cancer and Acute Lymphoblastic Leukemia. In particular, much of their work with Childhood Cancer has involved BCR-ABL1 positive patients, or patients who are CD22 positive.
Is Wendy Stock, MD currently recruiting for clinical trials?
Yes, Wendy Stock, MD is currently recruiting for 7 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Wendy Stock, MD has studied deeply?
Yes, Wendy Stock, MD has studied treatments such as Inotuzumab Ozogamicin, Venetoclax, Cytarabine.
What is the best way to schedule an appointment with Wendy Stock, MD?
Apply for one of the trials that Wendy Stock, MD is conducting.
What is the office address of Wendy Stock, MD?
The office of Wendy Stock, MD is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.